Cardiovascular Imaging Equipment - Medical Devices Pipeline Assessment, 2017

Published : Aug-2017

No. of Pages : 118

order by fax Inquire before Buying request discount

Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Cardiovascular Imaging Equipment Overview 7
3 Products under Development 8
3.1 Cardiovascular Imaging Equipment - Pipeline Products by Stage of Development 8
3.2 Cardiovascular Imaging Equipment - Pipeline Products by Territory 9
3.3 Cardiovascular Imaging Equipment - Pipeline Products by Regulatory Path 10
3.4 Cardiovascular Imaging Equipment - Pipeline Products by Estimated Approval Date 11
3.5 Cardiovascular Imaging Equipment - Ongoing Clinical Trials 12
4 Cardiovascular Imaging Equipment - Pipeline Products under Development by Companies 13
4.1 Cardiovascular Imaging Equipment Companies - Pipeline Products by Stage of Development 13
4.2 Cardiovascular Imaging Equipment - Pipeline Products by Stage of Development 14
5 Cardiovascular Imaging Equipment Companies and Product Overview 15
5.1 Arineta Ltd. Company Overview 15
5.1.1 Arineta Ltd. Pipeline Products & Ongoing Clinical Trials Overview 15
5.2 Beth Israel Deaconess Medical Center Inc Company Overview 16
5.2.1 Beth Israel Deaconess Medical Center Inc Pipeline Products & Ongoing Clinical Trials Overview 16
5.3 CardioPaint Company Overview 17
5.3.1 CardioPaint Pipeline Products & Ongoing Clinical Trials Overview 17
5.4 Columbia University Company Overview 18
5.4.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 18
5.5 Evena Medical, Inc. Company Overview 20
5.5.1 Evena Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 20
5.6 FMI Technologies, Inc. Company Overview 21
5.6.1 FMI Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
5.7 GE Healthcare LLC Company Overview 22
5.7.1 GE Healthcare LLC Pipeline Products & Ongoing Clinical Trials Overview 22
5.8 Illumasonix LLC Company Overview 25
5.8.1 Illumasonix LLC Pipeline Products & Ongoing Clinical Trials Overview 25
5.9 King's College London Company Overview 26
5.9.1 King's College London Pipeline Products & Ongoing Clinical Trials Overview 26
5.10 Medistim ASA Company Overview 27
5.10.1 Medistim ASA Pipeline Products & Ongoing Clinical Trials Overview 27
5.11 Nano4Imaging GmbH Company Overview 30
5.11.1 Nano4Imaging GmbH Pipeline Products & Ongoing Clinical Trials Overview 30
5.12 Perinatronics Medical systems Inc Company Overview 31
5.12.1 Perinatronics Medical systems Inc Pipeline Products & Ongoing Clinical Trials Overview 31
5.13 Purdue University Company Overview 32
5.13.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview 32
5.14 Terumo Corp Company Overview 33
5.14.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 33
5.15 University Health Network Company Overview 34
5.15.1 University Health Network Pipeline Products & Ongoing Clinical Trials Overview 34
5.16 University of Colorado Company Overview 35
5.16.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 35
5.17 University of Glasgow Company Overview 36
5.17.1 University of Glasgow Pipeline Products & Ongoing Clinical Trials Overview 36
5.18 Vibronix Inc. Company Overview 37
5.18.1 Vibronix Inc. Pipeline Products & Ongoing Clinical Trials Overview 37
5.19 Volcano Corp Company Overview 38
5.19.1 Volcano Corp Pipeline Products & Ongoing Clinical Trials Overview 38
5.20 Wisconsin Institute of Nuclear Systems Company Overview 44
5.20.1 Wisconsin Institute of Nuclear Systems Pipeline Products & Ongoing Clinical Trials Overview 44
6 Cardiovascular Imaging Equipment- Recent Developments 45
6.1 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 45
6.2 Jun 21, 2017: HeartFlow Names Former J&J Chairman and CEO William C. Weldon Chairman of the Board 47
6.3 Jun 20, 2017: DIA Imaging Analysis Ltd is the New Name of DiACardio, Expanding its Vision in Medical Imaging 47
6.4 Jun 19, 2017: Conavi Medical Welcomes Peter Wehrly to the Board of Directors 48
6.5 Jun 12, 2017: Kieran Murphy Appointed CEO of GE Healthcare, Succeeding John Flannery 48
6.6 Jun 07, 2017: Calgary Scientific Optimizes Partner and Customer Relationships with Updates to Leadership Team 49
6.7 Jun 01, 2017: HeartFlow Names Healthcare Industry Veteran Michael Buck as Executive Vice President and Chief Commercial Officer 49
6.8 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 50
6.9 May 23, 2017: KARL STORZ Wins Inter Partes Review Trial Invalidating Novadaq Patent 53
6.10 May 08, 2017: Stereotaxis Reports 2017 First Quarter Financial Results 53
6.11 May 03, 2017: NOVADAQ Announces First Quarter 2017 Financial Results 54
6.12 May 01, 2017: Conavi Medical Receives 510(k) Clearance from the FDA for the Foresight Intracardiac Echocardiography (ICE) System now Equipped with Color Doppler, 2D and 3D Measurements, and Enhanced 3D Visualization 55
6.13 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 55
6.14 Apr 27, 2017: Medistim: Results for the First Quarter 2017 56
6.15 Apr 26, 2017: LeMaitre Q1 2017 Record Sales $24.1 mm (+19%), Net Income $3.2 mm (+49%) 60
6.16 Apr 20, 2017: Applications Open for ASRT Foundation and Toshiba Medical Safety FiRsT Grant Program 60
6.17 Mar 28, 2017: LiDCO Group Announces Final Results 61
6.18 Mar 17, 2017: Philips showcases data-driven cardiology solutions at 2017 American College of Cardiology Conference 62
6.19 Mar 16, 2017: Siemens Healthineers and HeartFlow Collaborate to Provide Solution That Has Potential to Lower Cardiac Care Costs 63
6.20 Mar 13, 2017: Conavi Medical Announces Health Canada Approval of the Foresight Intracardiac Echocardiography System 63
6.21 Mar 10, 2017: IMRIS, Deerfield Imaging appoints Robert C. Korn as Senior Vice President - Global Sales and Marketing 64
6.22 Mar 01, 2017: LIDCO GROUP: Board Changes 64
6.23 Feb 28, 2017: NOVADAQ Announces Fourth Quarter And Full Year 2016 Financial Results 66
6.24 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 67
6.25 Feb 21, 2017: LeMaitre Q4 2016 Record Sales $23.3 mm (+14%), Op. Income $3.9 mm (+27%) 70
6.26 Feb 20, 2017: Medistim: Results for the Fourth Quarter 2016 70
6.27 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 71
6.28 Feb 06, 2017: Stereotaxis Announces Management Transition and 2016 Financial Results 71
6.29 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 73
6.30 Jan 10, 2017: Lidco Group: Appointment of Head of North America 75
6.31 Jan 10, 2017: NOVADAQ Announces Preliminary Unaudited Fourth Quarter 2016 Revenue And Issues 2017 Revenue Guidance 75
6.32 Dec 14, 2016: Stereotaxis Launches Interface Between Niobe Es System And Philips' State-of-the-art X-ray System 76
6.33 Dec 12, 2016: VIDA Diagnostics names new COO 76
6.34 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 77
6.35 Nov 21, 2016: Toshiba Medical Angiography Systems Help Clinicians Maximize Flexibility, Minimize Exposure and Optimize Image Quality in Interventional Radiology 80
6.36 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 81
6.37 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 81
6.38 Nov 07, 2016: Stereotaxis Reports 2016 Third Quarter Financial Results 82
6.39 Nov 02, 2016: NOVADAQ Reports Third Quarter 2016 Financial Results 83
6.40 Nov 01, 2016: GE Healthcare enhances single-use manufacturing capabilities with facility expansion and automation 84
6.41 Oct 30, 2016: ILUMIEN III Clinical Trial Results from St. Jude Medical Demonstrate Important Findings with Advanced Intravascular Imaging Technology 85
6.42 Oct 30, 2016: Study Examines use of Optical Coherence Tomography Compared to Intravascular Ultrasound and Angiography to Guide Coronary Stent Implantation 86
6.43 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 87
6.44 Oct 26, 2016: LeMaitre Q3 2016 Record Sales $23.2 mm (+22%), Record Op. Income $5.3 mm (+61%) 89
6.45 Oct 24, 2016: St. Jude Medical Announces Data to be Presented as Late-Breaking Clinical Trials and Highlights Its Latest Cardiovascular Portfolio at the 2016 TCT Conference 89
6.46 Oct 20, 2016: Medistim: Results for the Third Quarter 2016 90
6.47 Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results 92
6.48 Oct 11, 2016: LiDCO GROUP: Interim Results for the six months ended 31 July 2016 94
6.49 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 98
6.50 Sep 27, 2016: Stereotaxis Announces Recruitment of Highly Experienced Board Members 99
6.51 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 99
6.52 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 100
6.53 Aug 24, 2016: Medistim: 2nd quarter and 1st half report for 2016 103
6.54 Aug 23, 2016: Philips showcases full suite of cardiology solutions for personalized approach to prevention, diagnosis and treatment of cardiovascular disease at ESC Congress 2016 107
6.55 Aug 10, 2016: Arineta CT FDA Clearance 108
6.56 Aug 09, 2016: Stereotaxis Reports 2016 Second Quarter Financial Results 109
6.57 Jul 31, 2016: Toshiba and AHRA Open Applications for Ninth Annual Putting Patients First Program 111
6.58 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016 111
6.59 Jul 27, 2016: NOVADAQ Reports Second Quarter 2016 Financial Results 113
6.60 Jul 27, 2016: LeMaitre Q2 2016 Record Sales $22.4mm (+13%), Record Op. Income $3.8mm (+35%) 114
7 Appendix 115
7.1 Methodology 115
7.2 About GlobalData 118
7.3 Contact Us 118
7.4 Disclaimer 118

1.1 List of Tables
Table 1: Cardiovascular Imaging Equipment - Pipeline Products by Stage of Development 8
Table 2: Cardiovascular Imaging Equipment - Pipeline Products by Territory 9
Table 3: Cardiovascular Imaging Equipment - Pipeline Products by Regulatory Path 10
Table 4: Cardiovascular Imaging Equipment - Pipeline Products by Estimated Approval Date 11
Table 5: Cardiovascular Imaging Equipment - Ongoing Clinical Trials 12
Table 6: Cardiovascular Imaging Equipment Companies - Pipeline Products by Stage of Development 13
Table 7: Cardiovascular Imaging Equipment - Pipeline Products by Stage of Development 14
Table 8: Arineta Ltd. Pipeline Products & Ongoing Clinical Trials Overview 15
Table 9: SpotLight CT - Product Status 15
Table 10: SpotLight CT - Product Description 15
Table 11: Beth Israel Deaconess Medical Center Inc Pipeline Products & Ongoing Clinical Trials Overview 16
Table 12: XFM Interventional Guidance System - Product Status 16
Table 13: XFM Interventional Guidance System - Product Description 16
Table 14: CardioPaint Pipeline Products & Ongoing Clinical Trials Overview 17
Table 15: CardioPaint Device - Product Status 17
Table 16: CardioPaint Device - Product Description 17
Table 17: Columbia University Pipeline Products & Ongoing Clinical Trials Overview 18
Table 18: Electromechanical Wave Imaging System - Product Status 18
Table 19: Electromechanical Wave Imaging System - Product Description 18
Table 20: Myocardial Elastography - Ischemia - Product Status 19
Table 21: Myocardial Elastography - Ischemia - Product Description 19
Table 22: Evena Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 20
Table 23: Eyes-On Glasses 3.0 - Product Status 20
Table 24: Eyes-On Glasses 3.0 - Product Description 20
Table 25: FMI Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
Table 26: ScintiStar Cardiac LPX PET/CT - Product Status 21
Table 27: ScintiStar Cardiac LPX PET/CT - Product Description 21
Table 28: GE Healthcare LLC Pipeline Products & Ongoing Clinical Trials Overview 22
Table 29: ViosWorks - Product Status 22
Table 30: ViosWorks - Product Description 22
Table 31: GE Healthcare LLC - Ongoing Clinical Trials Overview 23
Table 32: ViosWorks - The Effectiveness of 4D Image Acquisition and Post-processing with Vios Works: A Phase Design Prospective Clinical Trial to Assess 4D Software Produced by GE and Arterys for Evaluating Cardiac Disease 24
Table 33: Illumasonix LLC Pipeline Products & Ongoing Clinical Trials Overview 25
Table 34: Echo PIV - Product Status 25
Table 35: Echo PIV - Product Description 25
Table 36: King's College London Pipeline Products & Ongoing Clinical Trials Overview 26
Table 37: Imaging Guidance System -Arrhythmia - Product Status 26
Table 38: Imaging Guidance System -Arrhythmia - Product Description 26
Table 39: Medistim ASA Pipeline Products & Ongoing Clinical Trials Overview 27
Table 40: MiraQ Cardiac - Product Status 27
Table 41: MiraQ Cardiac - Product Description 28
Table 42: MiraQ Ultimate - Product Status 28
Table 43: MiraQ Ultimate - Product Description 29
Table 44: Nano4Imaging GmbH Pipeline Products & Ongoing Clinical Trials Overview 30
Table 45: GraftVision - Product Status 30
Table 46: GraftVision - Product Description 30
Table 47: Perinatronics Medical systems Inc Pipeline Products & Ongoing Clinical Trials Overview 31
Table 48: MRI ECG Trigger - Product Status 31
Table 49: MRI ECG Trigger - Product Description 31
Table 50: Purdue University Pipeline Products & Ongoing Clinical Trials Overview 32
Table 51: 3D Visualization Laser - Product Status 32
Table 52: 3D Visualization Laser - Product Description 32
Table 53: Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 33
Table 54: Cardiovascular Imaging System - Product Status 33
Table 55: Cardiovascular Imaging System - Product Description 33
Table 56: University Health Network Pipeline Products & Ongoing Clinical Trials Overview 34
Table 57: Forward-Viewing Intravascular Imaging Device - Product Status 34
Table 58: Forward-Viewing Intravascular Imaging Device - Product Description 34
Table 59: University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 35
Table 60: Intra-Cardiac Camera System - Product Status 35
Table 61: Intra-Cardiac Camera System - Product Description 35
Table 62: University of Glasgow Pipeline Products & Ongoing Clinical Trials Overview 36
Table 63: SERS-Based System - Product Status 36
Table 64: SERS-Based System - Product Description 36
Table 65: Vibronix Inc. Pipeline Products & Ongoing Clinical Trials Overview 37
Table 66: Intravascular Photoacoustic System - Product Status 37
Table 67: Intravascular Photoacoustic System - Product Description 37
Table 68: Volcano Corp Pipeline Products & Ongoing Clinical Trials Overview 38
Table 69: Co-Reg + i/FFR - Product Status 38
Table 70: Co-Reg + i/FFR - Product Description 38
Table 71: FM Co-Reg - Product Status 39
Table 72: FM Co-Reg - Product Description 39
Table 73: Integrated IFR/CFR Platform - Product Status 39
Table 74: Integrated IFR/CFR Platform - Product Description 40
Table 75: Integrated OCT Platform - Product Status 40
Table 76: Integrated OCT Platform - Product Description 40
Table 77: IVI Co-Registration Platform - Product Status 41
Table 78: IVI Co-Registration Platform - Product Description 41
Table 79: LVOCT System - Product Status 41
Table 80: LVOCT System - Product Description 42
Table 81: OMNI Multi-Modality FM System - Product Status 42
Table 82: OMNI Multi-Modality FM System - Product Description 42
Table 83: Omni+ - Product Status 43
Table 84: Omni+ - Product Description 43
Table 85: Volcano OCT System - Second Generation - Product Status 43
Table 86: Volcano OCT System - Second Generation - Product Description 43
Table 87: Wisconsin Institute of Nuclear Systems Pipeline Products & Ongoing Clinical Trials Overview 44
Table 88: PC VIPR - Product Status 44
Table 89: PC VIPR - Product Description 44
Table 90: Glossary 117

1.2 List of Figures
Figure 1: Cardiovascular Imaging Equipment - Pipeline Products by Stage of Development 8
Figure 2: Cardiovascular Imaging Equipment - Pipeline Products by Territory 9
Figure 3: Cardiovascular Imaging Equipment - Pipeline Products by Regulatory Path 10
Figure 4: Cardiovascular Imaging Equipment - Pipeline Products by Estimated Approval Date 11
Figure 5: Cardiovascular Imaging Equipment - Ongoing Clinical Trials 12

Filed in: Medical Device, Orthopedic Devices

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027 “Increased cases of traumatic injuries and increasing surgical procedures worldwide are driving the overall growth of the wound care market” The global wound care market is projected to reach USD 27.2 billion by 2027 from USD 20.8 billion in 2022, at a CAGR of 5.4% during the forecast period. Market growth is driven by factors such as increase in traumatic injuries, increased in number of surgical wounds and increased spending on traumatic wound management. On the other hand, challenges associated with wound care product validation and shortage of skilled professionals are the major factors hampering the growth of this market. “The advanced wound care products segment accounted for the highest growth rate in the wound care market, by product, during the forecast period” T......	$8150
Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027 “The rehabilitation equipment market is projected to grow at a CAGR of 5.9% between 2022 and 2027.” The global rehabilitation equipment market is projected to reach USD 19.8 billion by 2027 from USD 14.9 billion in 2022, at a CAGR of 5.9% during the forecast period. Increasing geriatric population and obese populations, increasing chronic diseases, high risk of injuries to caregivers during the manual handling of patients, and increasing demand for rehabilitation care, owing to an increasing access to healthcare are the key driving factors in the market. However, a lack of awareness and access to rehabilitation services in emerging countries is a major factor restraining market growth. “Therapy equipment was the largest and fastest-growing segment in the product segment of reha......	$4950
Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027 "Increasing sports injuries and active participation are driving the overall growth of the cold pain therapy market." The global cold pain therapy market is projected to reach USD 2.4 billion by 2027 from USD 1.8 billion in 2022, at a CAGR of 5.1% during the forecast period. Growth in this market is mainly driven by growing incidence of arthritis and availability of cold pain products at affordable cost. "The OTC products segment accounted for the highest growth rate in the cold pain therapy market, by product, during the forecast period." The cold pain therapy market is segmented into OTC products and prescription products based on product. In 2021, the OTC products segment accounted for the highest growth rate in the cold pain therapy market. Market growth can largely be attri......	$4950
Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027 “Increasing research investments into the neurological compilations and the expanding geriatric population are pushing the growth of the nerve repair & regeneration market.” The global nerve repair & regeneration market is expected to reach USD 11.6 billion by 2027 from USD 6.5 billion in 2022, at a CAGR of 12.1%.The growth in this market is driven by increasing research expenditure on the neurological disorders by the government, the increasing R&D investments by the market players into the neuromodulation and neurostimulation devices and the biomaterials. Also, the expanding geriatric population base dries the growth of the market by placing more demand of the nerve repair and regeneration products. “The biomaterialas segment is anticipated to grow at the fastest ......	$4950
Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027 MarketsandMarkets expects particle therapy market is projected to reach USD 1,004 million by 2027 from USD 677 million in 2022, growing at a CAGR of 8.2% from 2022 to 2027. Market growth is driven by factors such as the various advantages offered by the growing global prevalence of cancer, particle therapy advantages over photon therapy, increasing acceptance of particle therapy in clinical trials, and the increasing number of particle therapy centers worldwide. However, affordability & accessibility of treatments and infrastructural are expected to limit market growth to a certain extent in the coming years. In this report, the particle therapy market is segmented on the basis of type, product and services, cancer type, application, cancer type, and region. “Treatment Applicat......	$4950
Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027 “The global restorative dentistry market is projected to grow at a CAGR of 6.1%” Restorative dentistry restores mouth functions & its aesthetic state by efficiently managing oral health problems through dental restoration. Dental restoration procedures include the use of implants and prosthetics made by restorative material to restore the function, integrity, and morphology of the missing tooth or to repair the missing parts of the tooth structure resulted from dental caries or injuries. The global restorative dentistry market is projected to reach USD 22.2 billion by 2027 from USD 16.5 billion in 2022, at a CAGR of 6.1%. “The prosthetic materials segment is expected to account for the largest share of the restorative dentistry market” The prosthetic materials segment ......	$4950
Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027 “Rapid growth in the geriatric population and the associated increase in the prevalence of edentulism is expected to drive the overall growth of the dental laboratories market.” Edentulism (tooth loss) is a major oral health concern among the elderly; according to the WHO (2020), globally, ~19% of individuals aged between 65 and 74 years are edentulous. Periodontal diseases and dental cavities are the major causes of tooth loss. As the elderly are more susceptible to such ailments, the growth of this population segment will increase the number of people suffering from oral health problems globally. According to the UN, the global geriatric population (aged 65 years and above) will increase from 703 million in 2019 to 1.5 billion in 2050. Thus, significant growth in the geriatric pop......	$4950
Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027) “Endoscope reprocessing market is projected to grow at CAGR of 9.7% from 2022 to 2027” The global endoscope reprocessing market is projected to USD 3.8 billion by 2027 from USD 2.4 billion in 2022, at a CAGR of 9.7% from 2022 to 2027.The growth of this market is driven owing to increasing requirement for endoscopy to diagnose and treat target diseases, high risk of Endoscope-associated infections due to contaminated endoscopes, Growing geriatric population and leading to increase in endoscopic procedures, and Increasing emphasis on improving reprocessing guidelines by healthcare authorities. Also, Increasing investments, funds, and grants to improve healthcare infrastructure and research areas of endoscopy is anticipated to offer an opportunity for the growth of the market during th......	$4950
Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027 “Rising demand from the electronics industry and expected recovery from impact of COVID-19 and rising penetration of EVs expected to drive market.” The global Polymethyl Methacrylate (PMMA) market is projected to grow from USD 4.8 Billion in 2022 to USD 6.3 Billion by 2027, at a CAGR of 5.4% during the forecast period. Increasing usage of PMMA in construction, automotive, electronics, and other end-use industries are driving the demand for PMMA during the forecast period. However, availability of low-cost substitutes is expected to hamper market growth. PMMA is a versatile, recyclable, sustainable, and durable material, owing to which it is gaining traction across several industrial applications. Due to its superior properties and the changing government policies such as European Gr......	$4950
Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027 “The hospital laboratories is projected to grow at CAGR of 7.1% from 2022 to 2027” Based on End user the market is classified into, The hospital laboratories, clinical laboratories, and other end users . The growth of this market is majorly driven by the increasing number of specialty diagnostic tests performed in hospital laboratories, rising number of in-house clinical diagnostic procedures in hospitals, rising number of hospitals across the globe, and the growing trend of establishing in-house clinical diagnostic capabilities in hospitals. “Microtome instruments in the product segment to witness the highest shares during the forecast period.” Based on the product, the microtome market is segmented into Microtome Instruments: Rotary Microtomes, Cryostat Microtomes, Vibra......	$4950

Cardiovascular Imaging Equipment - Medical Devices Pipeline Assessment, 2017

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027

Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027

Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027

Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027

Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027

Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027

Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027

Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027)

Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027

Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027